Selective targeting of activated T cells in chronic intestinal inflammation.
Weigmann
Benno
B
Institute of Molecular Medicine, University of Mainz, Mainz, Germany.
Neurath
Markus F
MF
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D053148:Caspase 3 / Q000235:genetics* / Q000378:metabolism; D002908:Chronic Disease; D003092:Colitis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006801:Humans; D007376:Interleukin-2 / Q000235:genetics* / Q000378:metabolism; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D008213:Lymphocyte Activation; D023421:Models, Animal; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000473:pathology
D007376:Interleukin-2; D011993:Recombinant Fusion Proteins; D053148:Caspase 3